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1Message from the BLiSS organisers 
Have you ever wondered what your peers do in their lab? What 
field they study? What fancy technique they are an expert of? Then 
found yourself bored out of your mind during a general conference 
because the talks are too specific and you still don’t get what the 
research is about?
BLiSS is a one-day symposium made for ECRs, by ECRs. This event 
will provide a unique opportunity for Life Science ECRs from all the 
major Universities and research institutes in and around Brisbane to:
• meet their peers
• share their research in an interesting and engaging format 
(digital interactive posters, short, punchy talks focusing on 
research impact and significance, showcasing cutting-edge 
technique)
• grow as a researcher (build meaningful connections,  
jump-start collaborations)
Other program highlights include a stellar plenary talk from Prof 
Marylin Renfree, panel discussions on “How to survive as a scientist” 
and “Gender equity in science”, and a fun-filled social mixer.
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2BLiSS 2016 themes 
The overall theme for BLiSS 2016 is “Our Next Challenges”. We 
want to gather all of the Brisbane Life Sciences ECR community 
together for an opportunity to share their research in an effort 
to create new collaborations and research projects to help solve 
today’s leading global issues.
Fighting disease and managing healthcare
This theme is aimed at research that aspires to 
prevent, better manage and develop innovative 
therapies to improve clinical and public health 
outcomes for both the population and the individual.
Sustaining the earth for 2100
Build Queensland’s and Australia’s capacity to  
respond to environmental change and integrate 
research outcomes from biological, physical, social  
and economic systems.
A head start on ageing and mental health
With census projections indicating the proportion of 
the population >65 years reaching 25% in the next 40 
years, research on improving the physical and mental 
well-being of the ageing population in society is a 
major goal. This theme is aimed at research promoting 
a better lifestyle to the adult and senior population.
The new frontier:  
technical and interdisciplinary advances
Breakthrough research often transcends the scope of  
a single discipline. This theme is aimed at research that 
integrates information, data, techniques, tools, and/or  
theories from two or more disciplines or bodies of 
specialized knowledge to accelerate scientific discovery.
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38:30 Registration
9:00 Welcome address
9:15 Plenary speaker: Prof Marilyn Renfree
10:00 Panel Discussion: How to survive as a scientist (Chair: Dr Kirsty Short)
A/Prof Kirsten Spann, Prof Bill von Hippel, Dr Amy Jennison, A/Prof Christian Gruber
10:45 Morning tea + poster session 1
11:30 The Auditorium
Fighting disease and  
managing healthcare
(Chair: Dr Ella Trembizki)
Oncology drug discovery 
in the next dimension
Dr Carrie Lovitt
Rethinking the role of  
antibodies in infectious diseases
Dr Charles Armitage
The underestimated 
potential of ultrasound
Dr Marie-Luise Wille
A new way to fight bacterial infections
Ms Signe Christensen
The antimicrobial effect of zinc
Dr Cheryl-Lynn Ong
The Forum
Understanding the  
mechanisms of disease
(Chair: Dr Alvin Lo)
Microbiome and blood pressure 
in early pregnancy
Dr Marloes Dekker Nitert
How mutations in sequence-specific 
transcription factors cause disease
Dr Kevin R. Gillinder
Murine model to study macrophage 
contributions to prostate cancer
Dr Andy Wu
Using transplantations to study 
chronic diseases and therapies
Dr Danielle Borg
Dissecting immunological networks 
in HPV-associated cancers
Dr Zewen Kelvin Tuong
12:40 Lunch
1:45 The Auditorium
A head start on ageing  
and mental health
(Chair: Dr Maryam Ziaei)
Paying attention  
to sleep in fruit flies
Dr Leonie Kirszenblat
Can our diet AGE us? Oral uptake 
and trafficking of dietary AGEs
Ms Amelia Fotheringham
Two hundred million years  
in the making of brain circuits
Dr Rodrigo Suárez
The contribution of neural crest  
to phenotypes in Down syndrome
Ms Anu Balachandran
Concurrent physiological measures 
to aid clinical psychiatric diagnosis
Mr Saurabh Sonkusare
The Forum
The new frontier: technical  
and interdisciplinary advances
(Chair: Dr Sohinee Sarkar)
Session sponsored by ANFF
Presentation of the ANFF
Dr Jane Fitzpatrick
Developing new mass spectrometry 
tools for analytical chemistry
Dr David Marshall
Beyond pretty models: single 
particle cryo-electron microscopy
Mr Lou Brillault
T-cell antigen formed from 
distinct metabolic pathways
Dr Jeffrey Mak
Modelling the molecular 
basis of disease
Dr Neha S. Gandhi
2:55 Afternoon tea + poster session 2
3:40 Panel Discussion: Gender equity (Chairs: Dr David Poger & Prof Marilyn Renfree)
Prof Bob Williamson, Dr Wafa El-Adhami, Prof Melissa Brown, Ms Julienne Clifford
4:25 Concluding remarks & prizes
4:30 Social mixer 7:30 End of the symposium
Program
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Australian National Fabrication Facility
Queensland Node
Australian National Fabrication Facility
Queensland Node
Providing micro and nano fabrication facilities 
for Australian researchers
www.anff.org.au
Facility Manager 
  Jane Fitzpatrick e: j.fitzpatrick1@uq.edu.au p: 07 3346 3460
Business Development Officer 
  Anita Gibson e: a.gibson1@uq.edu.au  p: 07 3346 3290
ANFF-Q helps researchers from areas as diverse as synthetic 
chemistry to waste water treatment, and from cell biology to 
organic electronics and everything in between.
We provide training, consultations, seminars and workshops 
to help you get the most out of our open-access state-of-the-
art fabrication and characterisation equipment and facilities. 
With simple and rapid access to cutting-edge tools and 
highly experienced staff, ANFF-Q can help you push for the 
next level of innovation.
Compounds Australia was established in 2008 and remains Australia’s only integrated compound
managementfacility, providing compound management research logistics (compound lodgement and
storage, specialized formatting and reformatting into assay-ready microplates, quality control, data
handling) to enhance drug discovery and translational research.
Compounds Australia – A Snapshot
Compounds Australia enables health and medical researchers to outsource the complexity of
compound storage and liquid handling robotics needed to prepare assay-ready microplates.
Compounds Australia seamlessly connects Australia’s chemistry research community with the
global bioscience research community to accelerate new discoveries of  bioactive molecules.
• Australian chemists
>670,000
compounds
•National compound collection
•24 member organisations
•>100 research projects/year
•Global bioscience 
community
> 2,000,000 assay 
data points/year
"Compounds Australia was the only facility 
of its kind in Australia that could manage 
chemical libraries required for high 
throughput screening".
Universities Australia Chair, 
Professor Barney Glover,
National Press Club, Mar 2016
Compounds Australia Members
www.compoundsaustralia.com
Playing a pivotal role in translation pathways to maximise opportunities for success
The demand for biochemical and cell-based
assays to enable in-depth analysis of compound
activities for medical research drives current drug
discovery eﬀorts.
Compounds Australia provides access to critical 
infrastructure and expertise to ensure ﬂexible, 
eﬃcient, reproducible and cost eﬀective 
compound management supporting biological 
characterisation of compounds throughout the 
drug discovery pipeline.
Tube 
Reformat-
ting
 Ability to provide nL and low uL quantities of 
samples in multiple assay-ready formats
 Microtube solubilisation and transfer into 
microplates
 Data tracking at all points of processing
Central to our facilities operations is expertise in laboratory automation, programming and customisation of software, large-scale data
management, workﬂow and process development, quality control protocol development and, above all the needs of world-class drug discovery research.
Four comPOUND® 100,000 1mL microtubes
One comPOUND® D2 200,000 0.5 mL microtubes
Compound & Sample Storage 
Compounds are curated, either in microtubes or 
microplates, under rigorous storage conditions 
(temperature, atmosphere, light, moisture) to 
maintain their integrity for an extended ‘shelﬂife’.
We have:
 Five TTP Labtech comPOUND® stores with total
capacity to hold 600,000 1.2 mL microtubes. These
compound storage units are at 90% capacity.
 Two Hamilton Storage Technologies PlateStoreII
(ASM Platestore) with total capacity to hold 4,200
microplates. The microplate storage units are at
83% capacity.
Assay 
ready 
plates
Sample 
Submis-
sions
Dedicated processing workﬂows
 Plate replication in 96, 384 and 1536 formats
(quadranted, dequadranted)
 Plate to plate cherry-picking in single- and multi-
volume formats in 96, 384 and 1536 microplate
 Generate IC50 curves via ECHO source and
intermediate concentrations and designing custom
plate layouts speciﬁc to customer needs
Compounds Australia 
Structure Portal 
launched in early 2016 enables 
researchers to browse or search the ‘Open’ 
Compound Collection via a web portal to further 
empower researchers with access to up-to-date 
information such as individual chemical properties
www.compoundsaustralia.com/casper.
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9The Central Analytical Research
Facility (CARF) is a group of
specialist laboratories at QUT,
supported by a team of expert
technical staff and research fellows.
CARF is a multi­user facility with
state­of­the­art instruments for
analysing the physical, mechanical,
chemical and biological properties of
solids, liquids and gases.
Phone +61 7 3138 9500 | Email carf@qut.edu.au  |  www.qut.edu.au/ife/carf
Analytical chemistry
Genomics
Histology
Micro and nano fabrication
Optical, electron and ion microscopy
Proteomics and small molecule mass
spectrometry
Stable isotope mass spectrometry 
Surface analysis
Physical and mechanical properties
X­ray diffraction and fluorescence
CRICOS No. 00213J
Contact us to find out how we can
help with your research. 
Our research capabilities
Queensland University of Technology’s Science and Engineering 
Faculty is advancing the frontiers of science and engineering 
to shape our future environments. We offer courses based on 
the real world in science, technology, engineering, mathematics 
(STEM) and urban development. This work drives the engines of 
growth that underpin modern society and have wide-reaching 
impact on our everyday lives.
Advancement 
through innovation
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1IMB RESEARCH SUPPORT FACILITIES
ACRF Cancer Biology Imaging 
Facility and ACRF Dynamic 
Imaging Facility
The Australian Cancer Research 
Foundation’s (ACRF) Cancer Biology 
Imaging Facility is one of the largest and 
most comprehensively equipped facilities in 
Australia for imaging and screening chemical 
and biological libraries. It is home to 23 high-
performance microscopes and provides on-
site expert technical support and training. It 
complements and extends the work of the 
ACRF Dynamic Imaging Facility, which was 
established in 2005.
imb.uq.edu.au/acrf-imaging-facilities
IMB Sequencing Facility
The IMB Sequencing Facility (ISF) provides 
sequencing services to IMB, UQ and 
the research community in the greater 
Brisbane region. The ISF provides services 
on Illumina’s NextSeq 500 and the MiSeq 
sequencing platforms. The facility offers 
sample preparation for sequencing of RNA 
from any species, whole exome sequencing 
for human DNA and whole genome 
sequencing for non-human species.
imb.uq.edu.au/ 
genomic-sequencing-facility
Mass Spectrometry Facility
IMB’s Mass Spectrometry Facility (MSF) 
provides researchers with state-of-the-art 
mass spectrometry, high-performance 
liquid chromatography and robotic 
instrumentation. The MSF provides 
technical advice and research and training 
support in a number of mass spectrometric 
applications, including investigating protein 
interactions and structures, amino acid 
sequence determination, post-translational 
modification discovery and quantification, 
compound stability, and bioavailability 
of potential therapeutics in a range of 
biological systems.
imb.uq.edu.au/mass-spectrometry-facility
IMB scientists have on-site access to a range of leading technologies and facilities,  
allowing them to conduct faster, more comprehensive research.
imb.uq.edu.au
Delivering  research  excellence
Innovative and dynamic research specialising in stem cell ageing and regenerative 
engineering, precision nanomedicine, advanced materials, nanoagriculture, and 
industrial biotechnology.
AIBN
Australian Institute for Bioengineering and Nanotechnology
Discover more at aibn.uq.edu.au
1800 007 900 info@scientifix.com.au  www.scientifix.com.au
CONTACT
Idris Mohammed
Ph 1800 007 900
M 0401 649 242
E idris@scientifix.com.au
Dynamica
Precisa
N-Biotek
UVP
D-Lab
Froilabo
Major Science
ABB
Scion Instruments
Bromic 
Macherey-Nagel
Takara Clontech Cellartis
Intron Biotechnology
LC Laboratories
ArticZymes
Duchefa
CareDx Olerup
Wak-Chemie
Hitachi
Suppliers
Promotions
Scientifix  Product Portfolio
• Ligation Free In-Fusion Cloning – 20% OFF 
• qPCR Premixes Enzymes – 40% OFF
• EmeraldAmp GT PCR – 20% OFF
• One-Step RT- qPCR – 20% OFF
• PrimeSTAR GXL – 20% OFF
• His-Tag Protein Purification – 15% OFF
• Oncogene Research ELISA Kits / Antibodies – 10% OFF + FREE plush toy 
• Multiplexing PCR Enzymes – 20% OFF 
• Macherey-Nagel Classics RNA and DNA Purification – 20% OFF
• Macherey-Nagel Plasmid DNA Transfection-Grade – 20% OFF kits OR 50% OFF Manifold
• NucleoZOL / RNA Isolation – Bundle Offer OR 20% OFF
• Disinfect MycoPlasma – FREE MycoClean up-size and Decontamination Kit
• Protein Markers – 50% OFF
• RedSafe EtBr Alternative – 20% OFF
• TimeTape Rainbow Pack – FREE tape dispenser
• PCR Decontamination – Sampling and 30% OFF
• gDNA Removal from RNA Preps - 30% OFF Heat&Run
• Scientifix Equipment – Bonus item at no extra charge
• Scientifix Comprehensive Equipment Brochure
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Australian Biosearch supports the Australian research community with 
innovative, and enabling, technologies and tools from world class suppliers.  
We provide antibodies, reagents, primary cells, media, ECM and kits for the 
emerging research areas of Epigenetics, Cancer research, Immunology, 
Neuroscience and all cell based Omics research.  
Want to contact us? 
 
  
Andrew Rayfield BSc PhD 
Life Science Consultant - 
Queensland 
Australian Biosearch 
 
Mobile: 0404 488 830 
Phone: 08-9302-2766 
Toll Free: 1800 858 797 
Fax: (08) 9302-4825 
 
Email: andrew@aust-biosearch.com.au 
Website: www.aust-biosearch.com.au 
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tomorrow’s 
thinkers
The brain is the most complex and intri-
cate machine known to humanity. It 
moves us, motivates us and defines us. 
The Queensland Brain Institute (QBI) at 
The University of Queensland is a 
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learns. Inspired by imagination, our 
work is powered by science.
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BLiSS online
Share your thoughts with us on the  
"Brisbane Life Science ECR Symposium" Facebook page.
Connect on Twitter 
@BLiSS_2016 
#ecr_bliss16
Any questions you want to ask during the panel discussions or  
the general discussion of each oral "Big challenge" session?  
Tweet and tag your burning question! 
#ecr_bliss16 
Find out more about BLiSS at: 
bliss2016.org
What's your BLiSS? the competition
We are excited to announce an Instagram/Twitter competition 
themed ‘What’s your BLiSS at work?’ Is it the perfect experiment, 
a publication acceptance or just hanging out with your group over 
that steaming cuppa? Upload a photo and tag #ecr_bliss16 any 
time before or during BLiSS for a chance to win prizes on the day!
Passport Stamp Competitions
Visit our Sponsor Expo and collect all 10 stamps. Post in  
the Sponsor Passport Box to get a chance to win a great prize!
Visit our Facility Expo and collect 5 out of 10 stamps. Post in  
the Facility Passport Box to get a chance to win a great prize! 
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O-01  
Oncology drug discovery in the next dimension 
Carrie J. Lovitt, Todd B. Shelper and Vicky M. Avery 
Discovery Biology, Eskitis Institute for Drug Discovery, Griffith University, QLD
Drug discovery and development programs 
depend on disease-relevant in vitro models. 
In the field of oncology, cells cultured in mon-
olayer conditions are often employed, however 
these pre-clinical models do not always mimic 
the complex milieu of cancer (Figure 1) and 
drug candidates for this disease may lack clin-
ical efficacy. The objective of this research was 
to increase the relevancy of in vitro pre-clini-
cal models for cancer drug discovery through 
development of advanced three-dimensional 
(3D) cell culture models suitable for examina-
tion novel chemical compounds, profiling drug 
candidates and elucidation of drug resistance 
mechanisms. For this research, cutting-edge 
technology including liquid handling robot-
ics and automated high content imaging and 
analysis methodology was utilised to evaluate 
drug candidates and deconstruct molecular 
mechanisms in advanced 3D cellular models.
Figure 1. The complex, heterogeneous microen-
vironment of tumours. The main elements of a 
tumour are tumour-specific and tumour-associated 
cells, structural components and chemical gradi-
ents. Modelling tumours utilising 3D cell culture 
technologies facilitates recapitulation many perti-
nent tumour elements1.
1 C Lovitt, T Shelper, V Avery. Expert Opinion Drug Discovery. 2016, 11, 885-
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O-02  
Rethinking the role of antibodies  
in mucosal infections
Charles W Armitage1, Richard S Blumberg2, Kenneth W Beagley1 
1Institute of Health and Biomedical Innovation, QUT, Brisbane, QLD, AUS 
2Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 
How your research fits into the bigger 
picture: The majority of successful vaccines 
rely on antibody-mediated protection tar-
geting a pathogens surface proteins, yet 
many pathogens also have an intracellular 
niche. Chlamydia trachomatis is an intracellu-
lar bacterium that replicates inside host cells 
allowing it to hide from the immune system, 
thus the vast majority of vaccines have tar-
geted the extracellular phase of infection. 
We have demonstrated that antibodies to 
the extracellular phase bind Chlamydia and 
paradoxically enhance epithelial uptake and 
infection1-2. Furthermore we provided the first 
evidence that antibodies travelling through 
epithelia can bind and neutralise intracellular 
chlamydial growth1,3. These data provide evi-
dence that targeting intracellular antigens is 
an interesting avenue in vaccine design. 
The key questions that you are trying 
to answer: Identifying additional antigens 
and the mechanism of intracellular antibody 
neutralisation, and how the immune system 
clears infection represents a novel approach 
in vaccine design to intracellular pathogens. 
The unique techniques you use in your 
experiments: GMO cells and mice, protein 
production and purification, flow cytome-
try, confocal microscopy, microbiology and 
immunology techniques. 
Figure 1. Antibodies play an 
intracellular and extracellular role 
in pathogen clearance. Immu-
noglobulin G (IgG) trafficking 
through the epithelial cytoplasm 
can interact with chlamydial 
inclusion membrane and Type 3 
Secretion System (T3SS) proteins 
which upregulates lysosomal 
fusion, protein degradation and 
flagging infected cells for killing 
by cytotoxic CD8+ T cells.
1C Armitage, C O’Meara, M Harvie, P Timms, R Blumberg, K Beagley. Immunol Cell Biol. 2014 92(5) 417-26 
2C Armitage, C O’Meara, A Kollipara, A Carey, R Blumberg, K Beagley. Immunol Cell Biol. 2016 (submitted) 
3C Armitage, R Blumberg, K Beagley. 2016 In preparation 
Dr Charles Armitage 
Affiliation, Country: Institute of Health and Biomedical Innovation, QUT, Australia
Phone: +617 3138 6252 E-mail: Charles.armitage@qut.edu.au 
Personal History: 
2004-2008 BAppSci (Hons) QUT 
2009-2013 PhD (Immunology and microbiology) @ QUT 
2013-present Postdoctoral Research @ QUT 
Research interests: Mucosal infections, immunology, microbiology, vaccine development.
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O-03 
The underestimated potential of ultrasound 
Marie-Luise Wille, Christian M. Langton, Scott Wearing
Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia 
In a clinical context, ultrasound is commonly 
known as an imaging modality and primarily 
used in monitoring the developing foetus in 
obstetrics. Other applications include moni-
toring of the blood flow in the heart, guiding 
a biopsy needle in oncology, and assessing 
musculoskeletal tissues after injury. How-
ever, we are far from having exploited the 
full potential that ultrasound has to offer and 
while innovation and technology are focussing 
on improving X-ray, PET, and MRI, the feasi-
bility and associated costs for the patient are 
usually ignored. 
In my research I take advantage of the 
fact that ultrasound is a mechanical wave 
and therefore highly dependent upon density 
and structure of the propagated material. By 
applying a novel ultrasound signal process-
ing technique, I am exploring new avenues to 
find alternative and cost-effective methods to 
predict osteoporotic fracture risk or to moni-
tor tissue composition changes in the diabetic 
foot in order to prevent ulceration.
Figure 1. Prototype design of an 
ultrasound heel scanner which 
can measure the bone density 
or the tissue composition of the 
plantar fat pad. This handheld 
device may be easily transported 
in a carry bag and transmit the 
ultrasound signals via Bluetooth 
to a tablet computer. 
Dr Marie-Luise Wille 
Affiliation, Country: Institute of Health & Biomedical Innovation, Queensland University of 
Technology, Brisbane, Australia 
Phone: +61 3138 6236 E-mail: m.wille@qut.edu.au 
Personal History: 2008 MSc (Physics), University of Basel, Switzerland 
2009-2010 Research Fellow, Fraunhofer Institute, Germany 
6/2011-3/2015 PhD (Medical Physics), IHBI, QUT 
Since 3/2015 Postdoctoral Research Fellow, IHBI, QUT 
Research interests: ultrasound, medical imaging, signal processing, astrophysics
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O-04  
A new way to fight bacterial infections
Signe Christensen1, Morten Grøftehauge1,2, Begoña Hera1,3, Róisín McMahon1 and  
Jennifer L. Martin1,4
1Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, University of Queensland, 
St. Lucia, Queensland 4072, Australia
2School of Biological and Biomedical Sciences, Durham University, Durham DH1 3LE, UK
3La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia
4The Eskitis Institute, Griffith University, Brisbane Innovation Park, Nathan QLD 4111, Australia
The rise in antibiotic resistance is undermin-
ing our ability to treat an increasing range 
of bacterial infections and is a huge threat 
to public health worldwide1. Disulfide bonds 
provide structural bracing to numerous pro-
teins including those involved in bacterial 
pathogenesis2. Bacterial disulfide bond (DSB) 
proteins catalyze the formation of disulfide 
bonds and thus are potential targets for drug 
development. The primary enzyme in the 
DSB family is DsbA. DsbA enzymes share the 
same overall fold but have subtle variations 
on their surface3. A broader knowledge of the 
diversity of DsbAs supports the development 
of broad and narrow spectrum inhibitors of 
DsbAs. Here I present the characterization 
of the DsbA from the intracellular pathogen 
Chlamydia trachomatis (CtDsbA). The structure 
of CtDsbA was solved by X-ray crystallogra-
phy and reveals a typical DsbA fold (Figure 1). 
Functional assays shows that CtDsbA is an 
oxidase, although the least oxidizing DsbA 
studied to date.
Figure 1. The structure of CtDsbA was solved by 
X-ray crystallography to a resolution of 2.7Å. 
CtDsbA has a typical DsbA structure with a thiore-
doxin fold (dark blue) containing the active CXXC 
motif (yellow). In light blue is the inserted helical 
domain. CtDsbA has an additional, non-catalytic, 
disulfide (orange) only seen in three other DsbAs, 
as well as an unpaired cysteine (red), which has not 
been previously reported in a DsbA.
1Nat Rev Drug Discov. 2010, 9(9), p. 663.
2Bardwell JC, K McGovern, and J Beckwith. Cell. 1991. 67(3): p. 581-9
3McMahon, RM, L Premkumar, and JL Martin. Biochim Biophys Acta. 2014. 1844(8): p. 1391-401.
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O-05  
An antimicrobial role for zinc in innate immune 
defense against group A Streptococcus
Cheryl-lynn Y. Ong, Mark J. Walker, & Alastair G. McEwan
School of Chemistry and Molecular Biosciences and Australian Infectious Diseases Research Centre, The University 
of Queensland, St Lucia 4072, Australia.
Zinc deficiency is associated with increased 
susceptibility to bacterial infection. Here, we 
investigated the role of zinc in innate immune 
defense against Group A Streptococcus (GAS), a 
Gram-positive bacterial pathogen responsible 
for a wide spectrum of human diseases. We 
found that deletion of the czcD gene (encod-
ing a zinc efflux pump) reduced the ability 
of GAS to grow in the presence of zinc and 
increased accumulation of internal zinc. Fur-
thermore, the mutant displayed attenuation 
in the mouse and neutrophil assays and show 
that zinc at the site of infection is critical for 
host immune defense. We also demonstrated 
the mechanisms by which zinc exerts its toxic 
effect in GAS. As such, zinc efflux is an impor-
tant contributor to GAS pathogenesis and zinc 
may play a direct antibacterial role in innate 
immune defense against infection. To date, 
our data has provided new insight into the 
potential use of zinc as therapeutics against 
bacterial infections.
Dr Cheryl-lynn Y. Ong
Affiliation, Country: The University of Queensland, Australia
Phone: +61733651892 E-mail: y.ong@uq.edu.au
Personal History: 
2005 Graduated from UQ (B Environmental Science with Honours) 
2009 Graduated from UQ (PhD in Microbiology/Biochemistry) 
2009-2016 Postdoctoral research fellow at UQ 
Since 2016 Garnett Passe & Rodney Williams Memorial Foundation research fellow (UQ/QIMR)
Research interests: Microbiology, infectious diseases, metals in biology
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O-06  
Microbiome and blood pressure in early pregnancy
Luisa F Gomez-Arango1,2, Helen L. Barrett1,2,3, H. David McIntyre1,4, Leonie K. Callaway1,2,3,  
Mark Morrison5, Marloes Dekker Nitert *2,6 for the SPRING trial group
1School of Medicine, The University of Queensland, Brisbane Australia
2UQ Centre for Clinical Research, The University of Queensland, Brisbane Australia
3Obstetric Medicine, Royal Brisbane and Women’s Hospital, Brisbane Australia
4Mater Research, The University of Queensland, Brisbane Australia
5Diamantina Institute, Faculty of Medicine and Biomedical Sciences, The University of Queensland, Brisbane 
Australia
6School of Chemistry and Molecular Biosciences, The University of Queensland,Brisbane Australia
Background: Obese pregnant women have a 
higher risk of developing pregnancy-induced 
hypertension and preeclampsia. Outside 
pregnancy, the gut microbiome of obese 
individuals is different from normal-weight 
individuals. Low-grade inflammation is a 
hallmark of obesity. Metabolites excreted by 
bacteria in the gut microbiome may contrib-
ute to hypertension and inflammation. This 
study aimed to investigate if blood pressure 
and level of the inflammatory marker PAI-1 
are associated with altered gut microbiome 
composition in overweight and obese women 
in early pregnancy.
Methods: The composition of the gut 
microbiota was determined in 205 women at 
16 weeks gestation from the SPRING study 
with 16S rRNA sequencing. The expression of 
butyrate-producing genes in the gut micro-
biota was assessed by real-time PCR. PAI-1 
levels were measured in fasting serum of a 
subset of 70 women at 16 weeks gestation.
Results: Obese women had signifi-
cantly higher systolic and diastolic blood 
pressure than overweight women in early 
pregnancy. Systolic blood pressure was neg-
atively correlated with abundance of the 
butyrate-producing genus Odoribacter in the 
gut microbiome. Butyrate production capac-
ity by the bacteria in the gut microbiome was 
decreased in women with higher blood pres-
sure. PAI-1 concentrations were increased in 
obese pregnant women. PAI-1 was inversely 
correlated with expression of butyrate kinase 
and abundance of Odoribacter.
Conclusion: The results of this study 
show that in overweight and obese pregnant 
women at 16 weeks gestation, the abun-
dance of butyrate producing bacteria and 
butyrate production in the gut microbiota 
is significantly negatively associated with 
blood pressure and with PAI-1. Increasing 
butyrate-producing capacity may contribute 
to maintenance of normal blood pressure in 
overweight and obese pregnant women.
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O-07  
How mutations in the DNA-binding domain  
of sequence-specific transcription factors  
cause disease
Kevin R. Gillinder1, Graham W. Magor1, Andrew C. Perkins1,2
1Mater Research - University of Queensland, Translational Research Institute, Brisbane, QLD 4102, Australia
2The Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
The average human genome contains 
nearly 100 missense mutations within the 
DNA-binding domain (DBD) of various 
sequence-specific transcription factors (TFs)1. 
Missense mutations in the DBD of TFs are can 
alter both the affinity and the specificity of 
DNA-binding leading to disruption of gene 
regulation. Despite their medical importance, 
the consequence of these mutations remains 
largely unknown. To investigate this, we have 
generated missense mutations, modeling 
human disease2, in critical DBD residues of 
Krüppel-like factor-1 (KLF1), an essential TF 
required for nearly every aspect of red blood 
cell formation3. Combining Next- Generation 
sequencing techniques including chromatin 
immunoprecipitation (ChIP), chromatin con-
formation capture (Capture-3C), ATAC-seq, 
and 4sU-labelled RNA-seq, we aim to under-
stand how these mutations alter the affinity 
and specificity of DNA-binding, and distort 
transcription of direct target genes.
Figure 1. A missense mutation in KLF1 
confers an altered DNA specificity lead-
ing to anemia. During normal red cell 
formation KLF1 regulates target genes 
like b-globin and Alas2, through bind-
ing the sequence GGT-G[CT]G-GGN 
in the promoter or enhancer of genes. 
However, the E339D mutation, also 
known as Neonatal Anemia (Nan-KLF1) 
alters the specificity and affinity of this 
sequence, leading to dysregulation and 
ectopic gene expression.
1L Barrera, et al. Science. 2016 351, 1450–
1454
2L Arnaud, et al. The American Journal of 
Human Genetics. 2010 87, 721–727
3MR Tallack & AC Perkins. IUBMB Life. 
2010 62, 886–890
Dr Kevin Gillinder
Affiliation: Mater Research – University of Queensland, Australia:
Phone: +61 73343 7531 E-mail: kevin.gillinder@mater.uq.edu.au
Personal History: 1999-2002 BSc. Science (Hons) 
2009-2012 PhD in Stem Cell Science, Newcastle University UK 
Since 2013 Research Officer, Cancer Genomics Group, Mater Research – University of Queensland
Research interests: Genetics, Genomics, Bioinformatics, Transcription and Gene Therapy
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O-08  
Murine model to study macrophage  
functional contributions to prostate cancer  
lesion development 
Andy C Wu1, Yaowu He1, Amy Broomfield2, Nicoll J Paatan1,3, Brittney S Harrington1, Hsu-Wen 
Tseng1, Elizabeth A Beaven2, Deirdre M Kiernan4, Peter Swindle4, Adrian B Clubb4, Jean-Pierre 
Levesque1, Ingrid G Winkler1, Ming-Tat Ling3,5, Bhuvana Srinivasan2, John D Hooper1, Allison R Pettit1 
1Faculty of Medicine and Biomedical Sciences, Mater Research Institute-The University of Queensland, Translational 
Research Institute, Woolloongabba, Qld 4102, Australia. 
2Department of Anatomical Pathology, Mater Health Services, South Brisbane, Qld 4101, Australia. 
3School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research 
Institute, Woolloongabba, Qld 4102, Australia. 
4Department of Urology, Mater Health Services, South Brisbane, Qld 4101, Australia. 
5Institute for Health and Biomedical Innovation, Queensland University of Technology, Translational Research 
Institute, Woolloongabba, Qld 4102, Australia. 
Prostate cancer (PCa) is the most com-
monly diagnosed cancer in Australian men 
with high propensity to metastasise to bone 
which disrupt bone homeostasis and leads to 
tumour growth and development of patho-
logical osteoblastic/osteolytic lesions. Bone 
metastasis and associated skeletal complica-
tions increase mortality risk in PCa patients. 
Identification of approaches to disrupt the 
interplay between PCa cells and cells of the 
bone marrow environment will lead to addi-
tional treatment options for men with skeletal 
metastasis. Immune cells in particular mac-
rophages have been implicated in tumour 
development and its number correlate with 
disease progression in primary PCa. We have 
developed a murine immune-competent 
PCa bone growth model that mimics lesions 
observed in human PCa bone metastasis and 
this model permit us to explore macrophage 
functional contributions to PCa lesion pro-
gression. Our research will provide foundation 
knowledge toward the development of mac-
rophage-targeted therapies that may improve 
responses of established bone tumour to 
chemotherapy. 
Figure A. Immune competent 
mouse model of PCa growth in 
bone exhibit both osteoblastic 
and osteolytic lesions, a clinical 
feature commonly observed in 
patient samples. (i) Immunohis-
tochemistry staining for collagen 
type I shows pathologic woven 
bone (WoB) within the medulla 
adjacent to original cortical bone 
(CtB) and interspersed in regions 
of both dense tumour and hae-
matopoietic tissue. (ii) Enzymatic 
staining of TRAP, showing 
region of extensive osteolysis 
on existing bone surfaces (white 
arrowhead). Tm, tumour; Tb, 
trabecular bone.
Dr Andy C. Wu
Affiliation: Mater Research Institute-The University of Queensland, Translational Research 
Institute, Woolloongabba, Qld 4102, Australia
E-mail: andy.wu@mater.uq.edu.au
Research interests: skeletal fracture, cancer bone metastasis, macrophages, tissue engineering
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O-09  
Using transplantations to study chronic  
diseases and therapies
Danielle J Borg, Hui Tong, Michael McGuckin, Sumaira Hasnain
Inflammatory Diseases Biology and Therapeutics, Mater Research Institute–The University of Queensland, 
Translational Research Institute, Brisbane, Queensland, Australia.
Cellular transplantation is a viable therapy for 
several diseases. Cellular transplantation can 
be performed preclinically in murine hosts via 
various site-specific injection sites to further 
improve cell therapies and understand disease 
processes. The subcapsular space, located 
between the renal capsule and kidney is an 
ideal site for cellular transplantation due to 
its accessibility, containment of transplanted 
material, and ease of angiogenesis. With 
the aim to improve functional outcomes for 
islet transplantation, a cell therapy used for 
individuals with unstable type 1 diabetes, we 
used the renal subscapular space as a site for 
autologous, murine islet transplantation. Spe-
cifically using a chemically-induced model of 
diabetes, hyperglycaemic recipient mice were 
transplanted with a syngeneic islet mass under 
the kidney capsule. Islets were treated with a 
compound known to reduce isletstressor PBS 
(vehicle control). Post-transplant, this model 
allows for continual monitoring of graft func-
tion. Further processing of the graft can be 
performed after anephrectomy.
Figure 1. Illustration of renal 
subcapsular transplantationin 
anaesthetised mice. A small inci-
sion is made in the renalcapsule, 
tubing containing cells is inserted 
into subcapsular space, cells are 
released using a microsyringe 
into the renal space, tubing is 
retracted and small incision is 
cauterised.
Dr Danielle Borg
Affiliation, Country: Mater Research Institute–The University of Queensland,Translational 
Research Institute, Australia
Phone: +734437690 E-mail: danielle.borg@mater.uq.edu.au
Personal History: 
2005 BAppSci, QUT, Brisbane, Australia  
2006 BSci(Hons), QUT, Brisbane, Australia 
2007-2008 Research Assistant, Tissue Repair and Regeneration, IHBI, Brisbane, Australia 
2008-2012 PhD, Dresden International Graduate School of Biomedicine and Bioengineering, 
Dresden, Germany 
Since 2012 Post-doctoral Research Officer, Mater Research Institute, Brisbane, Australia 
Since 2013 Honorary Fellow, Level A, University of Queensland, Brisbane, Australia 
Research interests: Diabetes, Islet Biology, Biomaterials, Cell Biology, Physiology
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O-10  
Dissecting the immunological networks  
that changes in HPV-associated cancers
Zewen Kelvin Tuong, Paula Kuo, Andrew Zammit and Ian Frazer
The University of Queensland Diamantina Institute, Translational Research Institute
HPVs are epitheliotropic double-stranded 
DNA viruses that infect the basal keratino-
cytes on skin and mucous membranes. Most 
HPV infections are cleared rapidly by the 
immune system but extended virus persis-
tence, especially by ‘high-risk’ HPV types, 
is associated with the induction of local 
immunosuppression and increasing risk of 
dysplastic transformation of normal epithe-
lium1. We are interested in understanding the 
immunological consequences of HPV infection 
in cancers, including cervical cancer and oral 
cavity cancer. We combine molecular, immu-
nological and bioinformatics approaches to 
investigate the alterations to immune net-
works in transgenic mouse models of cervical 
pre-cancer2. In addition, we have recently 
used high-throughput sequencing technol-
ogy to investigate the impact of HPV on the 
mutation burden during cancer and to uncover 
critical components that may influence 
the immune landscape in HPV-associated 
skin and mucosal malignancies (Figure 1). 
We hope that our research will one day assist 
in better informing immunotherapy design 
and strategies.
Figure 1. Alterations to com-
plex genetic and immunological 
networks underscore the conse-
quence of HPV infection during 
cancer. Identification of the main 
pathways involved will aid in tai-
loring immunotherapy options 
for patients.
1Rodriguez AC et al. J Natl Cancer 
Inst. 2008. 100. 513-517
2Frazer IH, Leggatt GR & Mat-
tarollo SR. Annu Rev Immunol. 
2011. 29, 111-138
Dr Zewen Kelvin Tuong
Affiliation, Country: UQDI, TRI, Australia
Phone: +61734436979 E-mail: z.tuong@uqd.edu.au
Personal History: 
2011 BBiomedSc Hons 1, Stow Lab and Muscat Lab, IMB, UQ 
2012-2016 PhD, Stow Lab and Muscat Lab, IMB, UQ 
Since 2016 Post-Doc, Frazer Lab, UQDI, TRI
Research interests: Immunology, Bioinformatics, Metabolism
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O-11  
Paying attention to sleep in fruit flies 
Kirszenblat L, van Swinderen B 
Queensland Brain Institute, The University of Queensland 
The benefits of a good night’s sleep seem 
obvious, yet we still know little about the 
functions of sleep. One consequence of sleep 
deprivation is the degradation of attention. 
Interestingly, attention seems to be intimately 
linked with sleep throughout the animal king-
dom, as studies in humans and other animals 
suggest sleep is crucial for attention while 
attention processes drive sleep need1. We 
are investigating the relationship between 
sleep and attention in the model organism 
Drosophila, using novel behavioral paradigms 
to study visual attention and sleep, and 
state-of-the-art microscopy techniques to 
examine how these processes affect synaptic 
connectivity in the brain. We have found that 
sleep deprivation makes flies more distract-
ible, while genetically activating a molecule 
involved in sleep and plasticity makes flies 
less distractible. By studying relatively simple 
circuits of the fly brain, we aim to discover 
fundamental plasticity mechanisms of sleep 
that optimise attention. 
Figure. Evolution of sleep and 
cognitive capacities. Sleep has 
several functions that appear 
to have evolved as nervous sys-
tems became more complex. In 
simple nervous systems such 
as the nematode, C. elegans, 
sleep-like states are triggered 
by developmental stages and 
environmental stress, suggest-
ing these are primitive functions 
of sleep. In animals with more 
complex nervous systems (such 
as flies and mammals) a daily 
need for sleep emerged, most 
likely to cope with the plasticity 
demands of cognitive processes 
such as operant learning and 
selective attention.
1Kirszenblat L & van Swinderen B. Trends in Neurosciences. 2015. 38, 776–786.
Dr Leonie Kirszenblat 
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O-12  
Can our diet AGE us? Exploring oral uptake and 
trafficking of dietary AGEs modified proteins in 
healthy mouse models
Amelia K Fotheirngham1,2, Danielle J Borg1, Sherman S Leung1,2, Linda A Gallo1,2, Aowen 
Zhuang1, Nicole B Flemming1,2, Micheal S Ward1, Domenica McCarthy1, Michael McGuckin1,  
Josephine M Forbes1
1Mater Research-University of Queensland, Translational Research Institute, Woolloongabba, Queensland.
2School of Biomedical Sciences-University of Queensland, St Lucia, Queensland.
Advanced Glycation End Products (AGEs), 
are post translational modifications to pro-
teins, commonly seen in western diets. 
AGEs are known to affect glycaemic control, 
cause inflammation, accumulate with aging 
and associate with disease. Little is known 
about gastrointestinal absorption of dietary 
AGE modified proteins and their subsequent 
localisation to different tissues. Therefore, 
we used a near infrared (near-IR) labelled 
AGE-modified model protein (near-IR AGEs), 
deliver edit intra-gastrically to healthy adult 
mice and analysed their tissues, from 15min 
to 8 hrs after delivery to localize the near-IR 
AGEs. AGE modified proteins were pres-
ent in the circulation, duodenum and liver 
as both intact protein (66kD) and cleavage 
products (<20kD) within 15 minutes. Only 
cleavage products were found to be pres-
ent in the kidney and urine. The presence of 
intact dietary derived AGE modified protein 
in the circulation and tissues may have a role 
in exacerbating inflammation and disease 
pathology.
Figure 1. Schematic of oral 
delivery, uptake and trafficking 
of near infrared tagged model 
AGEs. Healthy adult mice were 
delivered AGE modified pro-
teins into the stomach to mimic 
ingestion. The near IR labelled 
AGEs appeared within the blood 
stream, duodenum and liver as a 
mix of un-cleaved, intact prod-
uct, or smaller digested products. 
The cleaved digested products 
were also found to be present in 
the kidney and the urine.
Ms Amelia K Fotheringham
Affiliation, Country: Mater Research-UQ, School of Biomedical Science-UQ, Queensland, Australia
Phone: (07) 344 37681 E-mail: amelia.fotheringham@mater.uq.edu.au
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Research interests: Advanced Glycation end product biology, Diabetes complications, dietary and 
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O-13  
Two hundred million years in the making  
of brain circuits
Rodrigo Suárez
Queensland Brain Institute, The University of Queensland
Several psychiatric and neurological condi-
tions are due to malformations of neuronal 
circuits in the cerebral cortex, a region of 
the brain only present in mammals. What 
general rules have guided brain formation 
across evolutionary time remains unknown. 
To address this, we compared magnetic res-
onance imaging, mapping of neuronal circuits, 
and gene expression analyses across mam-
malian species. Our findings reveal a 200 
million years old template of cortical connec-
tions, with shared genetic programs, neuronal 
architecture, and wiring features between 
hemispheres. Such an ancestral map pre-
dates the origin of the corpus callosum for 
more than 40 million years, and suggests the 
corpus callosum evolved in early placentals by 
exaptation of evolutionary-old mechanisms. 
These results reveal conserved developmental 
features that could be exploited to re-route 
cortical connections in congenital defects of 
cortical miswiring, and offer new insights 
to inform biomedical strategies aimed at 
improving mental health in individuals with 
neurodevelopmental disorders.
Figure 1. Ancient origin of a mammalian pro-
gram cortical connections. The cerebral cortex is 
only present in mammals, and consists of neurons 
organised in layers at the brain surface. The brain of 
other vertebrates, such as birds, is instead organised 
in clusters of neurons. The pattern of connections 
between hemispheres differs dramatically between 
birds and placentals (such as mice and humans). 
However, whether monotremes and marsupials 
share such patterns is currently unknown. Here 
we combined magnetic resonance imaging of the 
brains of platypus and dunnarts, with gene expres-
sion and circuit connectivity analyses and revealed 
an ancient map of bilateral connections that arose 
more than 200 million years ago.
Rodrigo Suárez, PhD
Title: ARC DECRA Research Fellow
Affiliation, Country: Queensland Brain Institute, The University of Queensland. Australia
Phone: +61 435 786 788; Fax: +61 7 3346 6301; E-mail: r.suarez@uq.edu.au
Personal History: 
2016 ARC DECRA Research Fellow, Queensland Brain Institute, The University of Queensland. 
2011-2015 Postdoctoral Research Fellow, Queensland Brain Institute, The University of Queensland. 
2010 PhD in Biomedical Sciences, University of Chile 
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Investigating the contribution of neural crest  
to phenotypes observed in Down syndrome 
A Balachandran, D Ovchinnikov and E Wolvetang 
Australian Institute of Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland, 
Australia 
Neural crest cells (NCCs) are transient, 
multipotent progenitors that emerge 3 weeks 
into human embryonic development. They 
migrate within the embryo differentiating 
into craniofacial bone and cartilage, cranio-
facial and enteric neurons and glia, pigment 
and smooth muscle cells. Abnormal NC 
development results in neurocristopathies 
including Hirshsprung’s disease, craniofacial 
and cardiac abnormalities. Infants with Down 
syndrome (DS) have >300 times higher risk 
for developing these congenital malforma-
tions warranting a closer examination of NC 
development in DS. 
We developed a SOX10 reporter line using 
CRISPR/Cas9 genome editing technology 
which along with an optimised protocol to 
differentiate human pluripotent stem cells 
(hPSCs) into SOX10+ NCCs allows us to effi-
ciently isolate these cells. A multi-omic study 
on SOX10+ cells combined with bioinformat-
ics tools was used to primarily identify unique 
cell surface markers as well as heterogene-
ity amongst SOX10+ cells. Currently, we are 
examining the molecular profile and migra-
tory capacities of neural crest from DS-hPSCs. 
Figure 1. Differentiation of SOX10 reporter hIPSC 
line to cells that express SOX10:mMaple which can 
be enriched for under puromycin selection.
Ms Anushree Balachandran 
Affiliation, Country: Australian Institute of Bioengineering and Nanotechnology, University of 
Queensland, Australia 
Phone: +61410856387 E-mail: a.balachandran@uqconnect.edu.au 
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Bachelors of Biotechnology (1st class honours), Flinders University, SA, Australia: July 2007–May 2011
Research interests: CRISPR/Cas9 genome editing, patient derived human pluripotent stem cell 
culture and differentiation, neural crest cells, multi-omic analyses combined with bioinformatics, 
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O-15  
Multiple concurrent physiological measures  
to aid clinical psychiatric diagnosis 
Saurabh Sonkusare1,2, Vinh Thai Nguyen1, Michael Breakspear1, Christine Guo1
1QIMR Berghofer, Brisbane, Australia
2School of Medicine, The University of Queensland, Brisbane, Australia
Descriptions of affective disorders clearly rec-
ognize some distinct changes in physiological 
features, yet in most clinical practice and 
research there is little actual use of physiolog-
ical measurement. The use of such measures 
to aid clinical diagnosis has been limited by 
poor reliability, validity and methodological 
advances. These physiologic changes could 
provide an objective method to aid a clinician 
in diagnosis or even monitoring treatment 
responses in patients with neuro-psychiatric 
disorders. 
I am validating and characterising the 
pattern of these changes underlying various 
emotions by employing multi-modal set of 
tools that measure physiological changes. 
Furthermore, this study will also gener-
ate data for facial expression tracking study 
which further compliments the eventual aim 
of objective diagnosis of neuro-psychiatric 
disorders.
Figure. LabNeuro: Multimodal data acquisition lab-
oratory. This image shows the subject wearing an 
EEG cap with electrodes attached to the fingers and 
arms (for measuring skin conductance and heart 
rate respectively)and thermal camera and video 
camera are focussed on the participant’s face. 
LabNeuro is running on the left monitor while the 
stimulus is displayed on the right monitor.
Mr Saurabh Sonkusare
Affiliation, Country: QIMR Berghofer and University of Queensland, Australia
Phone: 469760984 E-mail: Saurabh.Sonkusare@qimrberghofer.edu.au
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O-16  
Developing new mass spectrometry tools  
for the analytical chemistry toolbox
David L. Marshall, Berwyck L. J. Poad, and Stephen J. Blanksby
Central Analytical Research Facility, Queensland University of Technology, Brisbane 4001 
Analytical chemistry is fundamentally con-
cerned with identifying and quantifying 
molecules in complex matrices. Even with 
modern instrumentation and software, anal-
ysis of structurally diverse molecular targets 
presents a significant challenge. This daunt-
ing task is exaggerated for the non-specialist 
researcher tasked with determining molecu-
lar function and requires an interdisciplinary 
approach to maximise data quality. 
The QUT Mass Spectrometry Development 
Laboratory advances novel instrumenta-
tion for the analytical chemistry community, 
especially for resolving impasses where con-
ventional techniques are unable to provide 
a complete picture. Differentiating isomeric 
lipids (e.g., omega-3 and omega-6 fats) is 
difficult when identification is primarily based 
on molecular mass! We study the interaction 
of ionised lipids with laser radiation or gase-
ous reagents inside a mass spectrometer to 
discern subtle structural differences. By stud-
ying the dissociation of multiple isomers in 
the presence of ozone, we have shown that 
Drosophila produce only a single isomer of a 
pheromonal triacylglycerol (Figure 1)1.
Figure 1. Sequential collision-induced dissociation 
(CID) and ozone-induced dissociation (OzID) of tri-
acylglycerols inside a modified mass spectrometer 
unequivocally identifies the molecular structure of 
a pheromone, and demonstrates that only a single 
isomer is produced. 
1 Marshall, H Pham, M Bhujel, J Chin, J Yew, K Mori, T Mitchell, S Blanksby. Anal Chem. 2016, 88, 2685-2692
Dr David Marshall 
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O-17  
Beyond pretty models: how single particle  
cryo-electron microscopy is used to understand 
macromolecular complexes
Lou Brillault1, Garry Morgan2, Kenneth Goldie3, Mohamed Chami3, Henning Stahlberg3,  
Alan Munn4, Ben Hankamer1, Frank Sainsbury5 & Michael Landsberg6
1 Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, 
St Lucia QLD 4072, Australia
2 Centre for Microscopy and Microanalysis, The University of Queensland, St Lucia, QLD 4072, Australia
3 Center for Cellular Imaging and Nano-Analytics (C-CINA), Biozentrum, University of Basel, CH-4058 Basel, 
Switzerland
4 School of Medical Science, Griffith University, Southport QLD 4222, Australia
5 Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD 4072, 
Australia
6 School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia QLD 4072, Australia
Since its development, cryo-electron micros-
copy (cryo-EM) has been a promising 
technique accompanying Xray crystallogra-
phy and NMR for the structural investigation 
of protein complexes. The recent advances 
in imaging with Direct Electron Detectors 
(DED) and single particle analysis software 
have dramatically improved the resolution 
of 3D reconstruction starting the so-called 
“resolution revolution”. Here I describe how 
we optimised single particle cryo-EM anal-
ysis for the characterisation of two different 
macromolecular complexes: The vacuolar pro-
tein sorting 4 (Vps4) oligomer, a key enzyme 
hijacked by enveloped viruses (HIV, Ebola and 
Herpes simplex) to mediate their infection 
and the Bluetongue virus core-like particle 
(BTV-CLPs) a RNA free viral capsid used for 
encapsidating foreign proteins with therapeu-
tic potential. The cryo-EM study of both of 
these particles will aid the therapeutic devel-
opment of new anti-virals targeting host 
proteins, as well as the design and modifica-
tion of virus-like nanoparticles for biomedical 
and nanotechnology applications.
Figure 1. cryo-EM 3D reconstruction of empty 
recombinant BTV CLPs refined to sub-nanometer 
resolution.
Mr Lou Brillault
Affiliation, Country: The University of Queensland, Australia
E-mail: l.brillault@uq,edu.au
Personal History: 
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O-18  
T-cell antigen formed from distinct metabolic pathways
Jeffrey Y. W. Mak1, Alexandra J. Corbett2, Sidonia B. Eckle2, Richard W. Birkinshaw3, Ligong Liu1, 
Onisha Patel3, Jennifer Mahony4, Zhenjun Chen2, Rangsima Reantragoon2, Bronwyn Meehan2, 
Hanwei Cao2, Nicholas Williamson5, Richard A. Strugnell2, Douwe Van Sinderen4,6, Lars Kjer-
Nielsen2, Jamie Rossjohn3,7, James McCluskey2, David P. Fairlie1
1Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, 
and Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Queensland
2Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of 
Melbourne, Parkville, Victoria
3Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, 
Victoria, and Australia Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash 
University, Clayton, Victoria
4School of Microbiology, University College Cork, Cork, Ireland
5The Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria
6Alimentary Pharmabiotic Centre, University College Cork, Cork, Ireland
7Institute of Infection and Immunity, Cardiff University, School of Medicine, Heath Park, Cardiff CF14 4XN, UK
Mucosal associated invariant T-cells (MAIT 
cells) are an abundant population of innate-
like human T cells in the blood1, liver2 and gut 
mucosa2-4. Their activation via the T cell receptor 
(TCR) upon presentation of bacterially derived 
antigens by an MHC class-I related molecule 
(MR1) has been implicated in pathological pro-
cesses such as inflammatory bowel disease4 and 
the immune response to pulmonary bacterial 
infection5. Although the identity of the anti-
gen(s) had been elusive, we recently discovered 
that an unstable riboflavin-type metabolite 
binds to MR1 and then activates MAIT cells1,6. 
It is formed in vivo via the condensation of 
5-amino-6-Dribitylaminouracil (5-A-RU, 1), 
a key bacterial riboflavin biosynthetic inter-
mediate, and pyruvaldehyde (2), a metabolite 
of glycolysis. Through chemical synthesis, MS 
and NMR characterization, the solution struc-
ture of this unstable antigen was determined 
unambiguously as 5-(2-oxoethylideneami-
no)-6-D-ribitylaminouracil (5- OP-RU, 3), 
which readily undergoes degradative cyclization 
to give lumazine 4. The MAIT TCR-MR1-anti-
gen crystal structure revealed the formation of 
a Schiff base between MR1 Lys43 and 5-OP-
RU stabilizing the antigen. Together, these show 
an unexpected mechanism of generating T-cell 
antigens by using disparate chemicals from dif-
ferent metabolic pathways.
1Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan 
B, Liu L, Bhati, M, Chen Z, Kostenko L, Reantragoon 
R, Williamson NA, Purcell AW, Dudek N L, McConville 
MJ, O'Hair RAJ, Khairallah, GN, Godfrey DI, Fairlie DP, 
Rossjohn J, McCluskey J. Nature. 2012, 491, 717.
2Huang S, Martin E, Kim S, Yu L, Soudais C, Fremont 
DH, Lantz O, Hansen TH. Proceedings of the National 
Academy of Sciences. 2009, 106, 8290.
3Kawachi I, Maldonado J, Strader C, Gilfillan S. Journal 
of immunology (Baltimore, Md : 1950). 2006, 176, 1618.
4Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, 
Marcelo P, Chatelain D, Barre A, Nguyen-Khac E, 
Lantz O, Dupas JL, Treiner E. Clinical and experimental 
immunology. 2014, 176, 266.
5Meierovics A, Yankelevich WJ, Cowley SC. Proceedings 
of the National Academy of Sciences of the United States of 
America. 2013, 110, E3119.
6Corbett AJ, Eckle SBG, Birkinshaw RW, Liu L, Patel O, Mahony 
J, Chen Z, Reantragoon R, Meehan B, Cao H, Williamson NA, 
Strugnell RA, Van Sinderen D, Mak JYW, Fairlie DP, Kjer-
Nielsen L, Rossjohn J, McCluskey J. Nature. 2014, 509, 361.
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O-19  
Modelling the molecular basis of disease
Neha S.Gandhi1 and Guy Lippens2
1School of Mathematical Sciences, Queensland University of Technology, Brisbane, Australia.
2 LISBP, Université de Toulouse, CNRS, INRA, INSA, Toulouse, France.
One of the grand challenges of modern 
biophysical science is to understand how 
intrinsically disordered peptides (IDPs) can 
fold into a unique, biologically functioning 
protein structure from the myriad conforma-
tions of the unfolded state. We combine the 
inherent power of high performance com-
puting and advanced molecular dynamics 
simulations algorithms to capture the confor-
mational changes in IDPs that typically occur 
on the millisecond time scale. Malfunction of 
a key IDP called Tau is the likely culprit behind 
Alzheimer's disease. It’s misfolding promotes 
aggregation and are toxic to the brain. Exper-
imental methods alone are generally too 
limited to provide the atomistic level of detail 
that is needed to characterize the molecular 
interactions that are involved. The combina-
tion of modelling with NMR techniques paves 
the way towards understanding how informa-
tion encoded in amino acid sequences of Tau 
governs its molecular function, contributes to 
organization of protein interaction networks 
and modulates the mechanisms of protein 
self-assembly..
Figure 1. Molecular dynamics simulations of 
structural characterisation of IDPs. Step 1 consists 
of defining a molecular mechanics force-field to 
calculate the potential energy of the protein as a 
function of the atomic coordinates. In step 2 a sim-
ulation box is defined that contains the coordinates 
of the Tau peptide, water and salt to mimic the 
experimental condition. Step 3 consists of numer-
ical integration of Newton’s equations of motion 
defined by the positions, forces and velocities of 
every atom in the simulation box. These equations 
are solved using the high performance computing 
facility. Steps 4, 5 and 6 involve the analysis and 
molecular interpretation of the terabytes of data 
produced by the simulation of the peptides leading 
to characterisation of their structural features.
Dr Neha S. Gandhi
Affiliation, Country: School of Mathematical Sciences and Institute of Health and Biomedical 
Innovation, Queensland University of Technology, 2 Gardens Point, Brisbane, Australia
Phone: +61 7 3138 7394 Fax: +61 7 3138 2310 E-mail: Neha.Gandhi@qut.edu.au
Personal History: 
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O-20  
Australian National Fabrication Facility
Jane Fitzpatrick 
The Australian National Fabrication facility was 
established by the Australian Government to 
provide access to the most advanced micro 
and nanofabrication tools to the Australian 
research community. Across our 8 nodes we 
provide support for projects that span every 
aspect of Australian research efforts, from 
food and agriculture through to astronomy 
and archaeology. This talk is a brief intro-
duction to the capabilities that you can find 
here in Queensland and some examples of the 
diverse and exciting research that we facilitate.
Dr Jane Fitzpatrick is the Facility Manager of ANFF-Q. Jane has a background in biotechnology 
where she worked in industry and academia, including a 3 year spell with an innovative biotech 
start-up company. She brings experience in business development and operations management from 
her previous roles and has a wealth of experience of the ANFF organisation through her involvement 
since 2010. She also has a focus on the development and support of the female members of our 
industry to ensure that the talent that we nurture is fully realised. As with all our staff, she is 
dedicated to the principles of open access, centralised facilities that support Australian researchers 
to achieve on a global scale.
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(MBA) size variation is associated with altered 
immune responses in vivo and in vitro
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